Fig. 5
From: The generation of hemagglutinin monoclonal antibodies against H9N2 influenza virus
Therapeutic efficacy of F4 mAb against lethal H9N2-115 infection. A Schematic illustration of the therapeutic trial. B Body weight change of mice infected with H9N2-115. C Survival rate of mice after virus challenge. D Virus titers in the lungs of infected mice (n = 3) at 3 dpi (left) and 5 dpi (right). Error bars represent means ± SDs. E Histopathological examination of lung slices from mice infected with H9N2-115 at 3 dpi and 5 dpi using hematoxylin and eosin (H&E) staining. Scale bars = 200 μm. (**, p<0.01; ***, p<0.001)